Lisata Therapeutics Inc (8NE.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
As of 08:32AM CEST. Market open.
| Previous close | 2.8000 |
| Open | 2.7200 |
| Bid | 2.6000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 2.7200 - 2.7200 |
| 52-week range | 1.8200 - 4.1600 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript
Lisata Therapeutics, Inc. (NASDAQ:LSTA) Q1 2024 Earnings Call Transcript May 9, 2024 Lisata Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Lisata Therapeutics First Quarter 2024 Financial Results and Business Update Conference Call. At this […]
- Thomson Reuters StreetEvents
Q1 2024 Lisata Therapeutics Inc Earnings Call
Q1 2024 Lisata Therapeutics Inc Earnings Call
- Zacks
Lisata's (LSTA) LSTA1 Gets FDA Orphan Drug Tag for Osteosarcoma
The FDA bestows an Orphan Drug designation to Lisata's (LSTA) lead investigational product candidate, LSTA1, for the treatment of osteosarcoma. Stock rises.
© 2024 Yahoo. All rights reserved.